Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 40,105 shares of the company’s stock, valued at approximately $210,000.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Integrated Quantitative Investments LLC acquired a new position in Aveanna Healthcare during the 2nd quarter worth about $167,000. Intech Investment Management LLC raised its position in shares of Aveanna Healthcare by 35.4% during the second quarter. Intech Investment Management LLC now owns 24,718 shares of the company’s stock worth $129,000 after acquiring an additional 6,469 shares during the last quarter. Creative Planning raised its position in shares of Aveanna Healthcare by 15.1% during the second quarter. Creative Planning now owns 47,025 shares of the company’s stock worth $246,000 after acquiring an additional 6,171 shares during the last quarter. Olympiad Research LP lifted its stake in shares of Aveanna Healthcare by 83.5% in the second quarter. Olympiad Research LP now owns 29,421 shares of the company’s stock worth $154,000 after acquiring an additional 13,385 shares during the period. Finally, Campbell & CO Investment Adviser LLC bought a new stake in Aveanna Healthcare in the second quarter valued at approximately $322,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.
Aveanna Healthcare Trading Up 0.5%
NASDAQ:AVAH opened at $9.32 on Friday. Aveanna Healthcare Holdings Inc. has a 12 month low of $3.67 and a 12 month high of $10.32. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39. The stock has a market capitalization of $1.95 billion, a price-to-earnings ratio of 25.88 and a beta of 2.04. The firm has a fifty day simple moving average of $9.03 and a two-hundred day simple moving average of $6.91.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on AVAH. Wall Street Zen raised shares of Aveanna Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 9th. JPMorgan Chase & Co. raised shares of Aveanna Healthcare from an “underweight” rating to a “neutral” rating and upped their price objective for the company from $6.00 to $10.00 in a research note on Thursday, September 18th. Jefferies Financial Group lifted their target price on shares of Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a research note on Tuesday, October 28th. Raymond James Financial upgraded shares of Aveanna Healthcare from a “market perform” rating to an “outperform” rating and set a $9.00 target price on the stock in a report on Monday, August 11th. Finally, Royal Bank Of Canada upped their price target on shares of Aveanna Healthcare from $8.00 to $10.00 and gave the company a “sector perform” rating in a research report on Friday, October 24th. Four research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $10.19.
View Our Latest Analysis on Aveanna Healthcare
Insider Activity
In other Aveanna Healthcare news, major shareholder Paul R. Vigano sold 1,500,000 shares of the business’s stock in a transaction on Friday, October 24th. The shares were sold at an average price of $9.00, for a total transaction of $13,500,000.00. Following the completion of the sale, the insider owned 362,746 shares in the company, valued at approximately $3,264,714. The trade was a 80.53% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, major shareholder Robert M. Williams, Jr. sold 1,500,000 shares of the company’s stock in a transaction on Friday, October 24th. The stock was sold at an average price of $9.00, for a total transaction of $13,500,000.00. Following the transaction, the insider owned 362,746 shares in the company, valued at approximately $3,264,714. The trade was a 80.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 32,597,968 shares of company stock worth $293,381,712 over the last quarter. 7.80% of the stock is currently owned by corporate insiders.
Aveanna Healthcare Company Profile
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
See Also
- Five stocks we like better than Aveanna Healthcare
- What is the Euro STOXX 50 Index?
- Meta Platforms May Ditch NVIDIA Chips—Here’s Why Investors Care
- 3 Warren Buffett Stocks to Buy Now
- SoFi Technologies: From Fintech Speculation to Profit Engine
- What is the Nasdaq? Complete Overview with History
- Gold to $5,000? What Bank of America and UBS Have to Say
Want to see what other hedge funds are holding AVAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Free Report).
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
